The 4-DSD: A New Tool to Assess Delirium Superimposed on Moderate to Severe Dementia.


Journal

Journal of the American Medical Directors Association
ISSN: 1538-9375
Titre abrégé: J Am Med Dir Assoc
Pays: United States
ID NLM: 100893243

Informations de publication

Date de publication:
07 2021
Historique:
received: 26 10 2020
revised: 22 01 2021
accepted: 18 02 2021
pubmed: 7 4 2021
medline: 6 8 2021
entrez: 6 4 2021
Statut: ppublish

Résumé

The purpose of this study was to create, standardize, and validate a new instrument, named 4-DSD, and determine its diagnostic accuracy in the diagnosis of delirium in subjects with moderate to severe dementia. Multicenter cross-sectional observational study. Older patients consecutively admitted to acute and rehabilitation hospital wards. The DSM-5 was used as the reference standard delirium assessment. The presence and severity of dementia was defined using the AD8 and the Global Deterioration Scale (GDS). The 4-DSD is a 4-item tool that ranges from 0 to 12. Item 1 measures alertness, item 2 altered function, item 3 attention, and item 4 acute change or fluctuation in mental status. A total of 134 patients were included in the study. Most of the patients were enrolled in acute hospital wards (60%), with 40% in rehabilitation settings. A minority of the patients were categorized with moderate dementia, with a GDS score of 5 (4%). Most of the patients were in the moderate-severe stage with a GDS score ≤6 (77%); 19% were classed as severe, with a GDS score of 7. A 4-DSD cutoff score ≥5 had a sensitivity of 80% and specificity of 80% with a positive predictive value (PPV) of 67% and a negative predictive value (NPV) of 89%. In the subgroup with moderate-severe dementia (n = 108), the sensitivity and the specificity were 79% and 82%, respectively, with a PPV and NPV of 62% and 92%. In the subgroup with severe dementia (n = 26) the sensitivity was 82% and the specificity 56% with a PPV of 78% and a NPV of 63%. The availability of a specific tool to detect delirium in patients with moderate-severe dementia has important clinical and research implications, allowing all health care providers to improve their ability to identify it.

Identifiants

pubmed: 33823162
pii: S1525-8610(21)00249-8
doi: 10.1016/j.jamda.2021.02.029
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1535-1542.e3

Informations de copyright

Crown Copyright © 2021. Published by Elsevier Inc. All rights reserved.

Auteurs

Alessandro Morandi (A)

Department of Rehabilitation, Fondazione Camplani Casa di Cura "Ancelle della Carità", Cremona, Italy; Geriatric Research Group, Brescia, Italy; Parc Sanitari Pere Virgili and Vall d'Hebrón Institute of Research, Barcelona, Spain. Electronic address: morandi.alessandro@gmail.com.

Eleonora Grossi (E)

Department of Rehabilitation, Fondazione Camplani Casa di Cura "Ancelle della Carità", Cremona, Italy; Geriatric Research Group, Brescia, Italy.

Elena Lucchi (E)

Department of Rehabilitation, Fondazione Camplani Casa di Cura "Ancelle della Carità", Cremona, Italy; Geriatric Research Group, Brescia, Italy.

Antonella Zambon (A)

School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy; Department of Statistics and Quantitative Methods, University di Milano-Bicocca, Milan, Italy; Istituto Auxologico Italiano, IRCCS, Biostatistic Unit, Milan, Italy.

Bianca Faraci (B)

Department of Rehabilitation, Fondazione Camplani Casa di Cura "Ancelle della Carità", Cremona, Italy; Geriatric Research Group, Brescia, Italy.

Jessica Severgnini (J)

Department of Rehabilitation, Fondazione Camplani Casa di Cura "Ancelle della Carità", Cremona, Italy.

Alasdair MacLullich (A)

Edinburgh Delirium Research Group, University of Edinburgh, Edinburgh, Scotland.

Heidi Smith (H)

Vanderbilt University Medical Center, Nashville, TN, USA.

Pratik Pandharipande (P)

Vanderbilt University Medical Center, Nashville, TN, USA.

Andrea Rizzini (A)

AFSSL, Social Healthcare Academy, PoliS Lombardia, Milan, Italy.

Marianna Galeazzi (M)

Geriatric Institute P Redaelli, Milano, Italy.

Francesca Massariello (F)

Geriatric Institute P Redaelli, Milano, Italy.

Samanta Corradi (S)

Neurologia, IRCCS INRCA, Ancona, Italy.

Alessandra Raccichini (A)

Neurologia, IRCCS INRCA, Ancona, Italy.

Antonia Scrimieri (A)

Geriatria, Accettazione geriatrica e centro di ricerca per l'invecchiamento, IRCCS INRCA, Ancona, Italy.

Valeria Morichi (V)

Geriatria, Accettazione geriatrica e centro di ricerca per l'invecchiamento, IRCCS INRCA, Ancona, Italy.

Simona Gentile (S)

Department of Rehabilitation, Fondazione Camplani Casa di Cura "Ancelle della Carità", Cremona, Italy; Geriatric Research Group, Brescia, Italy.

Flaminia Lucchini (F)

University of Florence, Careggi University Hospital, Florence, Italy.

Laura Pecorella (L)

University of Florence, Careggi University Hospital, Florence, Italy.

Enrico Mossello (E)

University of Florence, Careggi University Hospital, Florence, Italy.

Antonio Cherubini (A)

Geriatria, Accettazione geriatrica e centro di ricerca per l'invecchiamento, IRCCS INRCA, Ancona, Italy.

Giuseppe Bellelli (G)

School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH